It’s hard to escape Tamiflu ads in January. They’re just about everywhere – the gym, the DMV, you name it, the ads are there just in case you missed your flu shot and need some post-infection relief. What a lot of people don’t know is that Tamiflu is being used for more then just the common flu.
With renewed concerned over H7N9 bird-flu outbreaks, doctors are finding some success treating victims with Roche’s Tamiflu. Bowing to years of pressure, the manufacturer of Tamiflu released the clinical trial data for the blockbuster influenza vaccine.
Here a drug enjoying its January media spotlight, up +13 points at 56.
Interestingly enough, the media momentum appears to have fallen out from under the brand over the prior quarter. A good contrasting trend to watch is the underlying influenza coverage. Here’s quick glance at the level of attention being given (both through social and traditional channels) to the virus itself: